Article
Is interleukin-1 genotyping useful for the clinical management of patients with atrophic body gastritis?
Alimentary pharmacology & therapeutics - 15 Feb 2008
Lahner E, Corleto V D, D'Ambra G, Di Giulio E, Delle Fave G, Annibale B
Abstract excerpt
BACKGROUND: Atrophic body gastritis patients are at increased risk for gastric cancer. IL-1B/IL-1RN polymorphisms have been associated with gastric cancer susceptibility. The relationship between these polymorphisms and the long-term outcome of atrophic body gastritis patients is not known. AIM: To investigate whether the genotyping of IL-1B-511/IL-1RN polymorphisms is useful to characterize atrophic body...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
